In response to the study “a randomized trial of medical cannabis in patients with stage for cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient’s satisfaction” by Dr. Zylla and colleagues
Crossref DOI link: https://doi.org/10.1007/s00520-021-06768-8
Published Online: 2022-01-27
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Davis, Mellar P. http://orcid.org/0000-0002-7903-3993
Text and Data Mining valid from 2022-01-27
Version of Record valid from 2022-01-27
Article History
Received: 12 November 2021
Accepted: 15 December 2021
First Online: 27 January 2022